Generic pharmaceuticals are the safe, affordable alternative to brand-name drugs for your patients. Over the last 10 years (2003-2012), the Generic Pharmaceutical Association reports that the use of generic prescriptions in the United States saved the U.S. healthcare system approximately $1.2 trillion.2 Without the availability of these lower-cost generics, millions of Americans would not be able to afford the medicines they need.
Talk to your patients! Studies show that patients who talk with their healthcare provider about generics are more likely to fill their prescriptions with a generic drug and are more likely to adhere to their treatment regimen when prescribed a generic medication.4,10
Safety & Effectiveness
Generics undergo a rigorous review process by the U.S. Food and Drug Administration to ensure their quality prior to becoming available to patients. Manufacturers must submit an Abbreviated New Drug Application (ANDA) for review and approval, and each product is evaluated for drug components, drug stability, packaging, manufacturing processes, and facility descriptions.
All generic drugs must show bioequivalence to ensure that they have the same qualities and therapeutic equivalence to the FDA-approved brand-name drugs and will perform in the same manner. Bioequivalence replaces the need to complete animal studies, clinical studies, and bioavailability evaluations.
To learn more about generic medications, bioequivalence, and the FDA's approval process, download or request a copy of the Concise Consult: The Role of Generic Drugs in Patient Care and the Healthcare System.
2. Generic Pharmaceutical Association. Generic Drug Savings in the U.S. Fifth Annual Edition: 2013. http://www.gphaonline.org/media/cms/2013_Savings_Study_12.19.2013_FINAL.pdf. Accessed January 15, 2014
4. Shrank WH, Liberman JN, Fischer MA, et al. The consequences of requesting "Dispense as Written". Am J Med 2011;124(4):309-317.
10. Shrank WH, Liberman JN, et al. The consequences of requesting "Dispense as Written". Am J Med. 2011; 124(4):309-317.